Interstitial Pneumonitis and the Risk of Chronic Allograft Rejection in Lung Transplant Recipients
Andrew D. Mihalek(National Institute of Diabetes and Digestive and Kidney Diseases), Hilary J. Goldberg(Harvard University), Gary M. Hunninghake(Hubei University of Science and Technology), Robert F. Padera(Brigham and Women's Hospital), Anne L. Fuhlbrigge(Brigham and Women's Hospital), Iván O. Rosas(Brigham and Women's Hospital), Dawn L. DeMeo(Brigham and Women's Hospital), Phillip C. Camp(Brigham and Women's Hospital)
Cited by 3
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
|Nature Medicine|2008|1.3k
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Serum Vitamin D Levels and Markers of Severity of Childhood Asthma in Costa Rica
|American Journal of Respiratory and Critical Care Medicine|2009|635